Clinical TrialsSearch results
Number of results: 857
Other
- ALL-Ph18
- Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
- Shimada Hiroyuki
- 2019-09-18
Recruiting
- Alternative treatment of combined physical therapy for lymphedema
- Postsurgical breast cancer-related lymphedema
- Saeki Sota
- 2021-05-12
Recruiting
- AMG 193, Methylthioadenosine (MTA) Cooperative Protein Arginine Methyltransferase 5 (PRMT5) Inhibitor, Alone and in Combination With Docetaxel in Advanced Methylthioadenosine Phosphorylase (MTAP)-Null Solid Tumors
- Advanced MTAP-null Solid Tumors
- Iizumi Sakura
- 2022-04-15
Other
- An exploratory clinical trial to Investigate the efficacy and safety of Meclizine hydrochloride in Achondroplasia patients (pediatrics).
- Achondroplasia
- Matsushita Masaki
- 2023-04-03
Other
- An exploratory research for a case with peripheral artery disease as a complication of lumbar spinal canal stenosis.
- lumbar spinal canal stenosis
- Fukushima medical university school of medicine
- 2008-12-05
Recruiting
- An investigational study of chemoradiosensitivity prediction with genetic profiling of esophageal biopsy for squamous cell carcinoma of the esophagus
- Esophageal cancer
- University of Toyama
- 2007-02-01
Recruiting
- An observational study of i-gel Plus
- Non-cardiac and non-obstetric diseases for which supraglottic airway is indicated
- Nakanishi Toshiyuki
- 2024-02-27
Recruiting
- An Observational Study on Effectiveness and Safety of Akalux and BioBlade Laser System Based Illuminox Treatment in Patients with Locally Advanced or Recurrent Head and Neck Cancer
- Unresectable locally advanced or locally recurrent head and neck cancer
- Hanai Nobuhiro
- 2021-12-26
Not yet recruiting
- AN OPEN-LABEL CONTINUATION STUDY FOR PARTICIPANTS CONTINUING FROM ENCORAFENIB/BINIMETINIB CLINICAL STUDIES
- Locally advanced unresectable or metastatic melanoma with BRAFV600 mutation and previously untreated
- Oki Kosuke
- 2023-03-14
Other
- An Open-Label Randomized Phase III Study of Capecitabine(6 months) versus Capecitabine(12 months) as Adjuvant Chemotherapy for Stage III(Dukes'C) Colon Cancer Patients.
- Colon cancer
- Japanese Foundation for Multidisciplinary Treatment of Cancer
- 2008-09-10